Framework Contract for In-Vivo Studies on NB-PDX Models in Mice
Charité - Universitätsmedizin Berlin
Deadline 23 Oct 2026Notice summary
The Charité - Universitätsmedizin Berlin is issuing a framework contract for the conduct of in-vivo studies (therapy, characterization, or bio-distribution/pharmacokinetics studies) on patient-derived neuroblastoma xenograft models in mice ('NB-PDX models') along with the extraction of PDX tumor material. This is a framework contract with only one contractor. There are specific requirements according to the Berlin Procurement and Award Act (BerlAVG), see the award documents. …
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.